Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Healthcare

Page 38
  1. Apr 02, 2026 · 12:29 · WELL

    Well Health forms partnership with AliveCor

    Well Health forms partnership with AliveCor

    01
  2. Apr 02, 2026 · 09:43 · KETA · Routine −

    Tripsitter Clinic completes shares-for-debt settlement

    Tripsitter Clinic completes shares-for-debt settlement

    02
  3. Apr 02, 2026 · 08:30 · QNTM · Routine +

    Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied

    Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied

    03
  4. Apr 02, 2026 · 07:15 · RVX · Routine −

    Resverlogix Corp. Announces Issuance of MCTO by ASC

    Resverlogix Corp. Announces Issuance of MCTO by ASC

    04
  5. Apr 02, 2026 · 07:00 · WELL · Routine +

    WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians

    WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians

    05
  6. Apr 02, 2026 · 05:45 · ARCH · Routine +

    Arch Biopartners Closes Non-Brokered Private Placement

    Arch Biopartners Closes Non-Brokered Private Placement

    06
  7. Apr 01, 2026 · 22:50 · VPT

    Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group

    Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group

    07
  8. Apr 01, 2026 · 22:00 · MIR · Routine +

    MedMira Reports Second Quarter Results FY2025

    MedMira Reports Second Quarter Results FY2025

    08
  9. Apr 01, 2026 · 21:05 · EXE

    Extendicare closes $570M CHI Home Health acquisition

    Extendicare closes $570M CHI Home Health acquisition

    09
  10. Apr 01, 2026 · 15:45 · MBIO · Routine +

    MindBio Announces Closing of Private Placement

    MindBio Announces Closing of Private Placement

    10
  11. Apr 01, 2026 · 09:18 · EXE · Routine +

    Extendicare Acquires CBI Home Health

    Extendicare Acquires CBI Home Health

    11
  12. Apr 01, 2026 · 09:00 · OTC · Neutral

    Ocumetics to Showcase First-In-human Results with Industry Leaders & Potential Strategic Partners at ASCRS Annual Meeting

    Ocumetics to Showcase First-In-human Results with Industry Leaders & Potential Strategic Partners at ASCRS Annual Meeting

    12
  13. Apr 01, 2026 · 08:55 · ONCO · Neutral

    OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI

    OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI

    13
  14. Apr 01, 2026 · 08:02 · QNTM · Material +

    Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

    Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

    14
← Newer Older →